Synopsis Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. The global Smart Pi.....
Synopsis Fuel Card is used as a payment card most commonly for gasoline, diesel, and other fuels at gas stations. Fuel cards or gas cards, can help consumers’ business realize significant fuel savings and used to pay for vehicle maintenance and e.....
SynopsisBlinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. The global Blinatumomab market was valued at US$ 826 million in 2023 .....
SynopsisBlinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. The global Blinatumomab Drugs market was valued at US$ 826 million in.....
SynopsisBlincyto is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. The global Blincyto market was valued at US$ 512 million in 2023 and is anticipated to reach US.....
SynopsisClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Clofarabine Drugs market was valued at US$ 426 million in 2023 and i.....
SynopsisClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Clolar market was valued at US$ 426 million in 2023 and is anticipat.....
SynopsisClofarabine is a purine nucleoside antimetabolite in Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Evoltra market was valued at US$ 251 million in 2023 and is anticipated to reach US$ 428.6 million by 2030, w.....
Synopsisbuffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. The global Buffer.....
Synopsisbuffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. The global Buffer.....
